Leadership Corner Articles
As CEO of FFF Enterprises, Inc., Patrick Schmidt takes pride in his company’s success in helping to secure the specialty biopharmaceuticals marketplace over the past 26 years.
A deeper look at major risks in the healthcare industry, including lack of preventative care, inadequate care, adverse drug reactions and counterfeit drugs.
As U.S. Director of Sales & Marketing, Influenza, Chris Woolway is creating strategic partnerships to address industry challenges.
Just as it was impossible for previous generations to predict today’s scientific and technological advances, we are similarly challenged when looking to the future. But the path to progress begins with innovation.
In the 21st century, it is anticipated that vaccines will play an equally significant role, addressing issues that include increased life expectancy, emerging infections and childhood mortality in developing countries.
Dr. Ronald Sokol’s life work revolves around the research and treatment of childhood liver diseases and other pediatric disorders.
This safety-themed edition of BioSupply Trends Quarterly addresses this patient safety and how it can be improved.
Mark Harris, PhD, is the founder and chief executive officer of NextGxDx, a healthcare information company that provides a web-based genetic diagnostics marketplace.
In this plasma-themed issue of BioSupplyTrends Quarterly, we take a critical look at each of these segments of the plasma market.
Kedrion President and CEO Paolo Marcucci discusses Kedrion's goal to strengthen its role as strategic partner of national health systems.
In this issue, we explore novel technologies shaping the future of the healthcare landscape.
As we celebrate our third year in publication, we begin by exploring innovations in vaccine research and technology.